Presented by David Koo, Senior Transaction Partner, RoundTable
Please reserve your spot and REGISTER for this event.
Mr. Koo is a Senior Transaction Partner and has been at the firm since its inception. He is focused on the firm’s pharmaceutical related investments and is involved in all aspects of the transaction process, including deal sourcing, transaction structuring, valuation, due diligence, negotiations, financing, and execution. Mr. Koo serves on the boards of directors of Revision Skincare/Goodier Cosmetics, Renaissance Pharmaceuticals, Santa Cruz Nutritionals and Deerland Probiotics & Enzymes. He previously served on the boards of directors of Aqua, Avalign, Bioniche Pharma, CorePharma, MedAssist, and Vesta. Additionally, he was very involved throughout the Sabex investment as well as the investments in Vanguard and Argon. Mr. Koo joined RoundTable as a Principal.
RoundTable Investment Partners is a private investment partnership founded in 2006 by a group of successful and experienced entrepreneurs, executives and investors. Roundtable’s goal is to provide comprehensive wealth creation and legacy building services to help our investors efficiently and effectively achieve their lifestyle, philanthropic and intergenerational goals. Specifically, we offer integrated Strategic Advice & Planning, Investment Management and Merchant Banking solutions to families and institutions.
Originally published at ndigi.nd.edu.